The Living Guidelines: Patients with hyperthyroidism: Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Administration of a beta blocker is recommended to control the rate of ventricular response in patients with AF complicating thyrotoxicosis, unless contraindicated. (Level of Evidence: B)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class I Recommendation 1 for patients with hyperthyroidism should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. In circumstances when a beta blocker cannot be used, administration of a non dihydropyridine calcium channel antagonist (diltiazem or verapamil) is recommended to control the ventricular rate in patients with AF and thyrotoxicosis. (Level of Evidence: B)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class I Recommendation 2 for patients with hyperthyroidism should be: CLASS I CLASS IIa CLASS IIb CLASS III 3. In patients with AF associated with thyrotoxicosis, oral anticoagulation (INR 2.0 to 3.0) is recommended to prevent thromboembolism, as recommended for AF patients with other risk factors for stroke. (Level of Evidence: C)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class I Recommendation 3 for patients with hyperthyroidism should be: CLASS I CLASS IIa CLASS IIb CLASS III 4. Once a euthyroid state is restored, recommendations for antithrombotic prophylaxis are the same as for patients without hyperthyroidism. (Level of Evidence: C)

 ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class I Recommendation 4 for patients with hyperthyroidism should be: CLASS I CLASS IIa CLASS IIb CLASS III